Literature DB >> 7216487

Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora.

A B Onderdonk, M L Franklin, R L Cisneros.   

Abstract

Conventional guinea pigs provided with a solution of 5% (wt/vol) degraded carrageenan as the sole source of oral fluids developed ulcerations of their ceca and large intestines within 30 days. Similar lesions were not detected in germfree guinea pigs treated in an identical manner, suggesting that an intestinal microflora was necessary for development of intestinal lesions. To simplify the bacterial flora required for production of cecal ulcerations, 10 pools consisting of 10 bacterial strains each were isolated from the cecal microflora of carrageenan-treated animals. Groups of germfree guinea pigs were associated with 2 of the 10 pools by orogastric intubation and observed for development of disease. One-half of each group was treated with carrageenan. The two bacterial pools were characterized by the presence of cytopathic effects for WI-38 and Vero cells, increased chemotactic activity, and increased concentrations of long-chain fatty acids. The results indicated that animals associated with those two pools developed cecal ulcerations during carrageenan treatment. Preliminary results also indicated that cecal ulcerations developed in germfree animals mono-associated with a strain of Bacteroides vulgatus isolated from one of the pools, regardless of whether carrageenan was administered, suggesting a bacterial involvement in disease development in the absence of carrageenan treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7216487      PMCID: PMC350611          DOI: 10.1128/iai.32.1.225-231.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  The role of the intestinal microflora in experimental colitis.

Authors:  A B Onderdonk; J A Hermos; J G Bartlett
Journal:  Am J Clin Nutr       Date:  1977-11       Impact factor: 7.045

3.  A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease.

Authors:  R G Shorter; K A Huizenga; R J Spencer
Journal:  Am J Dig Dis       Date:  1972-11

4.  Bacteriological studies of experimental ulcerative colitis.

Authors:  A B Onderdonk; J G Bartlett
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

5.  Mitigation of experimental inflammatory bowel disease in guinea pigs by selective elimination of the aerobic gram-negative intestinal microflora.

Authors:  D Van der Waaij; B J Cohen; M R Anver
Journal:  Gastroenterology       Date:  1974-09       Impact factor: 22.682

6.  Protective effect of metronidazole in experimental ulcerative colitis.

Authors:  A B Onderdonk; J A Hermos; J L Dzink; J G Bartlett
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

7.  Lipid chemotaxins isolated from culture filtrates of Escherichia coli and from oxidized lipids.

Authors:  S Sahu; W S Lynn
Journal:  Inflammation       Date:  1977-03       Impact factor: 4.092

8.  Specific strains of Bacteroides species in human fecal flora as measured by deoxyribonucleic acid homology.

Authors:  J L Johnson
Journal:  Appl Environ Microbiol       Date:  1980-02       Impact factor: 4.792

9.  Carrageenan-induced ulceration of the large intestine in the guinea pig.

Authors:  J Watt; R Marcus
Journal:  Gut       Date:  1971-02       Impact factor: 23.059

10.  Polymorphonulcear leukocyte chemotaxis toward oxidized lipid components of cell membranes.

Authors:  S R Turner; J A Campbell; W S Lynn
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  38 in total

Review 1.  Probiotics for the treatment of inflammatory bowel disease.

Authors:  Ganesh R Veerappan; John Betteridge; Patrick E Young
Journal:  Curr Gastroenterol Rep       Date:  2012-08

2.  An imbalance in mucosal cytokine profile causes transient intestinal inflammation following an animal's first exposure to faecal bacteria and antigens.

Authors:  B C Sydora; S M MacFarlane; M Lupicki; A L Dmytrash; L A Dieleman; R N Fedorak
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

3.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.

Authors:  H C Rath; H H Herfarth; J S Ikeda; W B Grenther; T E Hamm; E Balish; J D Taurog; R E Hammer; K H Wilson; R B Sartor
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

5.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Authors:  S J Ott; M Musfeldt; D F Wenderoth; J Hampe; O Brant; U R Fölsch; K N Timmis; S Schreiber
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  Serogrouping of Bacteroides vulgatus by the agglutination test.

Authors:  N Okamura; K Miyazaki; T Chida; K Niwayama; R Nakaya; Y Benno; T Mitsuoka
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

7.  Experimental models for ulcerative colitis.

Authors:  A B Onderdonk
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

8.  Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium.

Authors:  M Yamada; T Ohkusa; I Okayasu
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

9.  Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus.

Authors:  A B Onderdonk; R L Cisneros; R T Bronson
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

10.  Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge.

Authors:  A H Raouf; V Hildrey; J Daniel; R J Walker; N Krasner; E Elias; J M Rhodes
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.